Vote Scores

Home / Companies / Fulgent Genetics, Inc. / 15 May 2025

Meeting · year to 30 June 2025330 filers reporting

Fulgent Genetics, Inc.: meeting of 15 May 2025

Votes reported on Form N-PX, item by item

330 Form N-PX filers reported votes at the Fulgent Genetics, Inc. meeting of 15 May 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

4 nominees; 59.1% of reported votes for; 72 filers withheld from or voted against at least one nominee.

788 vote records from 98 filers. 47 of the 98 filers that marked the item either way voted against management.

44.9% for0.0% against55.1% other48.0% against management98 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

459 vote records from 326 filers. 158 of the 313 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

46.3% for49.4% against4.3% other50.5% against management326 filers68.7% for31.1% against0.2% other31.2% against management11,045,254 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

197 vote records from 98 filers. 4 of the 98 filers that marked the item either way voted against management.

95.9% for4.1% against4.1% against management98 filers99.4% for0.6% against0.6% against management5,892,559 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *ForFor
FidelityForForFor
DimensionalForAgainst *For
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
Franklin TempletonNo reportAgainst *No report
InvescoForAgainst *For
EquitableAbstain or withhold *ForFor
Charles SchwabForAgainst *For
Nuveen and TIAAForAgainst *For
ProShares and ProFundsAbstain or withhold *Against *For
John Hancock and ManulifeAbstain or withhold *Against *For
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganAbstain or withhold *ForFor
Goldman SachsAbstain or withhold *Against *For
PGIM and PrudentialForForFor
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceAbstain or withhold *Against *For
ThriventAbstain or withhold *Against *For
Lincoln FinancialForForFor
VoyaAbstain or withhold *Against *For
First TrustNo reportForNo report
Russell InvestmentsForForFor
NationwideSplit or no voteForFor
Victory CapitalAbstain or withhold *Against *For
Brighthouse FundsAbstain or withhold *Against *For
Guggenheim and RydexAbstain or withhold *Against *For
Columbia ThreadneedleAbstain or withhold *Against *For
BNY MellonAbstain or withhold *ForFor
PrincipalAbstain or withhold *Against *For
Pacific Life fundsSplit or no voteForFor
Global XForForFor
Federated HermesAbstain or withhold *ForFor
AllianceBernsteinNo reportAgainst *No report
DWSAbstain or withhold *Against *For
MassMutualNo reportForNo report
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Fulgent Genetics, Inc. meeting?

330 Form N-PX filers reported votes at the meeting of 15 May 2025. On say-on-pay, 158 of 313 voted against management (50.5%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Fulgent Genetics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Fulgent Genetics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Fulgent Genetics, Inc. with a meeting date within three days of 15 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.